scholarly article | Q13442814 |
P50 | author | Antonio Leonardi | Q56697366 |
Bruno Di Jeso | Q59661494 | ||
P2093 | author name string | Domenico Liguoro | |
Pasquale Vito | |||
Romania Stilo | |||
Luigi Formisano | |||
P2860 | cites work | Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB | Q22010046 |
c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB | Q22010238 | ||
Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins | Q24290511 | ||
Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB | Q24290546 | ||
CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappa B activation pathways | Q24291679 | ||
DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis | Q24683786 | ||
Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma | Q28118591 | ||
A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis | Q28139969 | ||
CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10 | Q28140452 | ||
Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-kappaB | Q28142782 | ||
CLAP, a novel caspase recruitment domain-containing protein in the tumor necrosis factor receptor pathway, regulates NF-kappaB activation and apoptosis | Q28199393 | ||
Apoptosis in the pathogenesis and treatment of disease | Q28235731 | ||
The CARD domain: a new apoptotic signalling motif | Q28239887 | ||
RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis | Q28270026 | ||
Death receptors: signaling and modulation | Q28280897 | ||
Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types | Q28297278 | ||
TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. | Q33951635 | ||
P433 | issue | 1-3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | NF-κB | Q411114 |
P304 | page(s) | 165-169 | |
P577 | publication date | 2002-06-01 | |
P1433 | published in | FEBS Letters | Q1388051 |
P1476 | title | TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation | |
P478 | volume | 521 |
Q40553244 | Analysis of the adaptor function of the LIM domain-containing protein FHL2 using an affinity chromatography approach |
Q44128971 | Association between CARD8 rs2043211 polymorphism and inflammatory bowel disease: a meta-analysis |
Q43781538 | CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation. |
Q35756869 | CARDINAL roles in apoptosis and NFkappaB activation |
Q39715701 | Caspase recruitment domain-containing protein 8 (CARD8) negatively regulates NOD2-mediated signaling |
Q44743510 | Clinical and molecular characteristics of isolated colonic Crohn's disease. |
Q37696275 | Dependence receptors: a new paradigm in cell signaling and cancer therapy |
Q24311368 | Evaluation of Nod-like receptor (NLR) effector domain interactions |
Q34479719 | Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study |
Q35137904 | FHL2 regulates hematopoietic stem cell functions under stress conditions |
Q39836295 | Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation |
Q34399565 | Identification of FHL2-regulated genes in liver by microarray and bioinformatics analysis. |
Q39248288 | Induction of apoptosis in oral epithelial cells by Candida albicans |
Q40486121 | Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin |
Q37122935 | LIM-only protein FHL2 activates NF-κB signaling in the control of liver regeneration and hepatocarcinogenesis |
Q49959192 | Long non-coding RNAs in ischemic stroke |
Q41684152 | Molecular Analysis of a Short-term Model of β-Glucans-Trained Immunity Highlights the Accessory Contribution of GM-CSF in Priming Mouse Macrophages Response. |
Q43433871 | No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohorts |
Q58709260 | Novel HDAC5-interacting motifs of Tbx3 are essential for the suppression of E-cadherin expression and for the promotion of metastasis in hepatocellular carcinoma |
Q81886839 | Oncogene functions of FHL2 are independent from NF-kappaBIalpha in gastrointestinal cancer |
Q49915054 | Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients |
Q47146914 | Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health |
Q42773665 | TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation |
Q21260428 | TUCAN/CARDINAL/CARD8 and apoptosis resistance in non-small cell lung cancer cells |
Q35534352 | The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation |
Q24323174 | The LIM-only protein FHL2 is a negative regulator of E4F1 |
Q28383855 | The PYRIN domain in signal transduction |
Q33748985 | The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex |
Q37115437 | The dark side of a tumor suppressor: anti-apoptotic p53. |
Q39963131 | The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities |
Q27678234 | The structure of the CARD8 caspase-recruitment domain suggests its association with the FIIND domain and procaspases through adjacent surfaces |
Search more.